Disparities in Guideline-Based Prescribing Exist for Heart Failure and Coronary Heart Disease Patients who have Intellectual/Developmental Disabilities in a Commercially Insured Database
Product Description:
Disparities exist in prescribing GBP for patients with IDD with CHD and HF conditions. Patients who have Down syndrome with CHD and HF should be examined by clinicians and policymakers to ensure appropriate access to GBP. Further work will be conducted to determine the causes of these disparities.
Keyword(s):
disparities, guideline based pharmacotherapy, heart failure atherosclerotic cardiovascular disease
Product/Publication Type(s):
Conference presentations and posters presented
Target Audience:
Professionals, Policymakers
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A